Raydiant Oximetry Secures FDA Approval for Lumerah Investigational Device Exemption (IDE) Study
April 10, 2024 12:04 ET
|
Raydiant Oximetry
The FDA has approved the Investigational Device Exemption (IDE) of Lumerah for an Early Feasibility Study (EFS) of pregnant women during labor and delivery